Targeting androgen signaling in ILC2s protects from IL-33-driven lung inflammation, independently of KLRG1.
Blanquart E, Mandonnet A, Mars M, Cenac C, Anesi N, Mercier P, Audouard C, Roga S, Serrano de Almeida G, Bevan CL, Girard JP, Pelletier L, Laffont S, Guéry JC.
Blanquart E, et al. Among authors: roga s.
J Allergy Clin Immunol. 2022 Jan;149(1):237-251.e12. doi: 10.1016/j.jaci.2021.04.029. Epub 2021 May 5.
J Allergy Clin Immunol. 2022.
PMID: 33964300
Free article.